bioRxivImmunology
TIGIT is upregulated by HIV-1 infection and marks a highly functional adaptive and mature subset of natural killer cells
E. Vendrame, C. Seiler, T. Ranganath, N. Q. Zhao, R. Vergara, M. Alary, A. C. Labbe, F. Guedou, J. Poudrier, S. Holmes, M. Roger, C. A. Blish
Abstract
ObjectiveOur objective was to investigate the mechanisms that govern natural killer (NK) cell responses to HIV, with a focus on specific receptor-ligand interactions involved in HIV recognition by NK cells.\n\nDesign and MethodsWe first performed a mass cytometry-based screen of NK cell receptor expression patterns in healthy controls and HIV+ individuals. We then focused mechanistic studies on the expression and function of T cell immunoreceptor with Ig and ITIM domains (TIGIT).\n\nResultsThe mass cytometry screen revealed that TIGIT is upregulated on NK cells of untreated HIV+ women, but not in antiretroviral-treated women. TIGIT is an inhibitory receptor that is thought to mark exhausted NK cells; however, blocking TIGIT did not improve anti-HIV NK cell responses. In fact, the TIGIT ligands CD112 and CD155 were not upregulated on CD4+ T cells in vitro or in vivo, providing an explanation for the lack of benefit from TIGIT blockade. TIGIT expression marked a unique subset of NK cells that express significantly higher levels of NK cell activating receptors (DNAM-1, NTB-A, 2B4, CD2) and exhibit a mature/adaptive phenotype (CD57hi, NKG2Chi, LILRB1hi, FcR{gamma}lo, Syklo). Furthermore, TIGIT+ NK cells had increased responses to mock-infected and HIV-infected autologous CD4+ T cells, and to PMA/ionomycin, cytokine stimulation and the K562 cancer cell line.\n\nConclusionsTIGIT expression is increased on NK cells from untreated HIV+ individuals. Although TIGIT does not participate directly in NK cell recognition of HIV, it marks a population of mature/adaptive NK cells with increased functional responses.
- organism: human
- assay: flow cytometry
- research focus: cell type annotation
- research focus: cell signaling & trafficking
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- NKp30 and NKG2D contribute to natural killer recognition of HIV-infected cells
Ruoxi Pi, Nancy Q. Zhao, … Catherine A. Blish·iSciencePeer-reviewed·Sep 13, 2025
- Combined Dendritic Cell And Anti-TIGIT Immunotherapy Potentiate Trail+ Memory NK Cells Against HIV-1 Infected Cells
I. S. Cerrillo, O. Popova, … E. Martin-Gayo·bioRxiv·Apr 9, 2024
- Early resident NK cell response to local HIV infection in lymphoid tissue
David Perea, Alba Gonzalez, … Maria José Buzón·bioRxiv·Feb 17, 2025
- Natural killer cell migration in HIV-infected individuals is inhibited by impairment of HIF-1alpha-mediated glycolysis
Xiaowen Yu, Jie Zhou, … Yongjun Jiang·Cell Death and DiseasePeer-reviewed·Nov 7, 2025
- NK cells acquire CCR5 and CXCR4 by trogocytosis in people living with HIV-1
M. Villalba, D.-N. Vo, … P. Corbeau·bioRxiv·Dec 21, 2021
- Loss of Vpr-driven TRAIL-R2 expression protects HIV-infected cells from non-canonical NK cell TRAIL attack
Paula E. Grasberger, Abigail Sondrini, … Kiera Clayton·bioRxiv·Apr 19, 2026